These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20021991)

  • 1. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
    Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
    J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.
    Houston JP; Lau K; Aris V; Liu W; Fijal BA; Heinloth AN; Perlis RH
    J Clin Psychiatry; 2012 Jun; 73(6):878-85. PubMed ID: 22480387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
    Vieta E; Berk M; Wang W; Colom F; Tohen M; Baldessarini RJ
    J Affect Disord; 2009 Dec; 119(1-3):22-7. PubMed ID: 19324419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
    Detke HC; DelBello MP; Landry J; Usher RW
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
    Citrome L
    Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of comorbid anxiety on treatment response in bipolar depression.
    Tohen M; Calabrese J; Vieta E; Bowden C; Gonzalez-Pinto A; Lin D; Xu W; Corya S
    J Affect Disord; 2007 Dec; 104(1-3):137-46. PubMed ID: 17512607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
    Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
    J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of FDA-approved treatment options in bipolar depression.
    McIntyre RS; Cha DS; Kim RD; Mansur RB
    CNS Spectr; 2013 Dec; 18 Suppl 1():4-20; quiz 21. PubMed ID: 24237641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
    Kemp DE; Ganocy SJ; Brecher M; Carlson BX; Edwards S; Eudicone JM; Evoniuk G; Jansen W; Leon AC; Minkwitz M; Pikalov A; Stassen HH; Szegedi A; Tohen M; Van Willigenburg AP; Calabrese JR
    J Affect Disord; 2011 Apr; 130(1-2):171-9. PubMed ID: 21071096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression.
    Dubé S; Tollefson GD; Thase ME; Briggs SD; Van Campen LE; Case M; Tohen M
    Bipolar Disord; 2007 Sep; 9(6):618-27. PubMed ID: 17845277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.